Generate Biomedicines, Inc.
GENB
DELAYED 1 MONTH
1 insider filing · Latest: Mar 4, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 4, 2026 | Mar 6 9:55 PM | Michael NallyDirector, Chief Executive Officer | Purchase | 20,000 | $12.00 | $240.0K | 572,707(D) | View → |
Stock Options & Derivatives
No transactions found.